Biogen (BIIB) Goodwill & Intangibles (2009 - 2026)

Biogen (BIIB) posted quarterly Goodwill & Intangibles of $15.5 billion for Q1 2026, down 3.23% year-over-year from $16.1 billion in Q1 2025, and down 0.81% on a QoQ basis from $15.7 billion in Q4 2025.

Biogen (BIIB) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Biogen (BIIB) has reported Goodwill & Intangibles for 18 consecutive years, with $15.5 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Goodwill & Intangibles fell 3.23% year-over-year to $15.5 billion; the TTM figure through Mar 2026 stood at $15.5 billion (down 3.23% YoY), while the FY2025 annual figure was $15.7 billion, down 3.1% from the prior year.
  • Goodwill & Intangibles came in at $15.5 billion for Q1 2026 at Biogen, down from $15.7 billion in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $16.3 billion in Q3 2024, with the low at $6.9 billion in Q3 2023.
  • Average Goodwill & Intangibles over 5 years is $12.2 billion, with a median of $14.5 billion recorded in 2024.
  • Across the five-year window, Goodwill & Intangibles retreated 10.87% in 2023 and surged 135.85% in 2024, its largest moves.
  • Year by year, Goodwill & Intangibles stood at $7.6 billion in 2022, then soared by 91.89% to $14.6 billion in 2023, then rose by 10.89% to $16.2 billion in 2024, then declined by 3.1% to $15.7 billion in 2025, then decreased by 0.81% to $15.5 billion in 2026.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $15.5 billion, $15.7 billion, and $15.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.54 Bn
Dec 31, 2025 15.67 Bn
Sep 30, 2025 15.82 Bn
Jun 30, 2025 15.96 Bn
Mar 31, 2025 16.06 Bn
Dec 31, 2024 16.17 Bn
Sep 30, 2024 16.29 Bn
Jun 30, 2024 14.46 Bn
Mar 31, 2024 14.51 Bn
Dec 31, 2023 14.58 Bn
Sep 30, 2023 6.91 Bn
Jun 30, 2023 7.53 Bn
Mar 31, 2023 7.57 Bn
Dec 31, 2022 7.60 Bn
Sep 30, 2022 7.75 Bn
Jun 30, 2022 7.82 Bn
Mar 31, 2022 7.91 Bn
Dec 31, 2021 7.98 Bn
Sep 30, 2021 8.05 Bn
Jun 30, 2021 8.15 Bn